FDA approves Ionis’ TRYNGOLZA for FCS treatment
The US Food and Drug Administration (FDA) has approved Ionis Pharmaceuticals' TRYNGOLZA (olezarsen), designed as an adjunct to diet for …
Post
-
-
Novo Nordisk takes a hit as CagriSema underperforms in weight loss
Danish mega-company Novo Nordisk has taken a hit after its newest experimental weight loss drug, CagriSema, fell short of expectations …
-
FDA confirms end of Eli Lilly’s tirzepatide shortage after re-evaluation
The US Food and Drug Administration (FDA) has stood by an earlier decision confirming that the tirzepatide shortage is over. The …
-
Setback for UK pharma as government sets unexpectedly high VPAG payback rate in 2025
The UK Department of Health and Social Care (DHSC) has announced its anticipated 2025 headline payback rate for new medicines …
-
Palleon and Shanghai Henlius Biotech link on autoimmune therapy
Palleon Pharmaceuticals and Shanghai Henlius Biotech have entered a licence agreement and partnership for the former’s sialidase enzyme therapeutic, E-602, …
-
Astellas and Sangamo sign capsid deal for neurological diseases
Astellas Pharma and Sangamo Therapeutics have signed a licence agreement for a neurotropic adeno-associated virus (AAV) capsid, STAC-BBB, aimed at …
-
Magazine: US reproductive laws could limit women’s participation in clinical trials
Two years have passed since the US Supreme Court’s decision in Dobbs vs Jackson Women’s Health to overturn the constitutional …
-
Vertex’s stock hurt after non-opioid pain drug shows benefit similar to placebo
Vertex Pharmaceuticals’s non-opioid-based pain therapy has shown benefit in a Phase II trial in patients with painful lumbosacral radiculopathy (LSR) …
-
FDA approves Mesoblast’s Ryoncil for SR-aGvHD treatment
Mesoblast has gained US Food and Drug Administration (FDA) approval for its mesenchymal stromal cell (MSC) therapy, Ryoncil (remestemcel-L), to …
-
MSD makes obesity play in up to $2bn deal for Hansoh’s GLP-1RA asset
Merck & Co (MSD) has entered an exclusive global licence agreement with China-based Hansoh Pharma for a preclinical oral small …
-
BioAge and Novartis seek drug targets for ageing-related diseases
BioAge Labs has entered a multi-year research partnership with Novartis to discover and validate new therapeutic drug targets that address …
-
Novo Holdings completes Catalent acquisition for $16.5bn
Novo Holdings has completed the previously announced acquisition of Catalent in a $16.5bn all-cash transaction. The European Commission (EC) gave its …
-
Pharma’s data and analytics market forecast to reach to $2.1bn by 2028
Data content management will drive the growing global data and analytics market in the pharmaceutical sector, which will reach a …
-
The healthcare sector must change its industrial refrigeration methods to reduce its emissions
Industrial refrigeration is key to the healthcare industry, but it contributes massively to its emissions. Several companies are starting to …
-
Abera and Orexo partner for vaccine powder formulations
Abera Bioscience and Orexo have entered a partnership to develop and test the powder formulations of the former’s vaccine candidates …
